Asylia Therapeutics is Drug Discovery in United States that focus on colon cancer business. Founded in 2019. They cover business area such as operator, scientific advance, safe and effective medicine, cancer, autoimmune and infectious disease, a drug pipeline, antigen presentation, anti-tumor response, healthcare provider, solid tumor, breast, multiple myeloma.
2019
( 5 years old in 2024 )
Colon Cancer
-
2450 Holcombe Boulevard
Suite J
Houston, TX 77021
United States
Private
operatorscientific advancesafe and effective medicinecancerautoimmune and infectious diseasea drug pipelineantigen presentationanti-tumor responsehealthcare providersolid tumorbreastmultiple myeloma
* We use standard office opening hours in near Asylia Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Asylia Therapeutics is Drug Discovery business from United States that founded in 2019 (5 years old in 2024), Asylia Therapeutics business is focusing on Colon Cancer.
Asylia Therapeutics headquarter office and corporate office address is located in 2450 Holcombe Boulevard Suite J Houston, TX 77021 United States.
Asylia Therapeutics was founded in United States.
In 2024, Asylia Therapeutics is currently focus on colon cancer sector.
Above is snippet of Google Trends for "colon cancer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Asylia Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
